Elizabeth J Videlock1, Wendy Shih2, Mopelola Adeyemo3, Swapna Mahurkar-Joshi4, Angela P Presson5, Christos Polytarchou6, Melissa Alberto7, Dimitrios Iliopoulos8, Emeran A Mayer9, Lin Chang10. 1. Oppenheimer Center for Neurobiology of Stress and Resilience, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, 10833 Le Conte Avenue, CHS 42-210, Los Angeles, CA 90095-7378, United States. Electronic address: evidelock@mednet.ucla.edu. 2. Department of Biostatistics David Geffen School of Medicine, University of California, Los Angeles, 10833 Le Conte Avenue, CHS 42-210, Los Angeles, CA 90095-7378, United States. Electronic address: wshih3737@gmail.com. 3. Oppenheimer Center for Neurobiology of Stress and Resilience, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, 10833 Le Conte Avenue, CHS 42-210, Los Angeles, CA 90095-7378, United States. Electronic address: maadeyemo@gmail.com. 4. Oppenheimer Center for Neurobiology of Stress and Resilience, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, 10833 Le Conte Avenue, CHS 42-210, Los Angeles, CA 90095-7378, United States. Electronic address: swapnajoshi@mednet.ucla.edu. 5. Division of Epidemiology, Department of Internal Medicine, University of Utah, 295 Chipeta Way, Salt Lake City, UT 84132, United States. Electronic address: angela.presson@hsc.utah.edu. 6. Oppenheimer Center for Neurobiology of Stress and Resilience, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, 10833 Le Conte Avenue, CHS 42-210, Los Angeles, CA 90095-7378, United States. Electronic address: cpolytarchou@gmail.com. 7. Oppenheimer Center for Neurobiology of Stress and Resilience, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, 10833 Le Conte Avenue, CHS 42-210, Los Angeles, CA 90095-7378, United States. Electronic address: melissa.alberto3@gmail.com. 8. Oppenheimer Center for Neurobiology of Stress and Resilience, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, 10833 Le Conte Avenue, CHS 42-210, Los Angeles, CA 90095-7378, United States. Electronic address: diliopoulos@mednet.ucla.edu. 9. Oppenheimer Center for Neurobiology of Stress and Resilience, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, 10833 Le Conte Avenue, CHS 42-210, Los Angeles, CA 90095-7378, United States. Electronic address: emayer@ucla.edu. 10. Oppenheimer Center for Neurobiology of Stress and Resilience, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, 10833 Le Conte Avenue, CHS 42-210, Los Angeles, CA 90095-7378, United States. Electronic address: linchang@mednet.ucla.edu.
Abstract
BACKGROUND AND AIMS: Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis has been reported in irritable bowel syndrome (IBS). Enhanced HPA axis response has been associated with reduced glucocorticoid receptor (GR) mediated negative feedback inhibition. We aimed to study the effects of IBS status, sex, or presence of early adverse life events (EAL) on the cortisol response to corticotropin-releasing factor (CRF) and adrenocorticotropic hormone (ACTH), and on GR mRNA expression in peripheral blood mononuclear cells (PBMCs). METHODS: Rome III+ IBS patients and healthy controls underwent CRF (1μg/kg ovine) and ACTH (250μg) stimulation tests with serial plasma ACTH and cortisol levels measured (n=116). GR mRNA levels were measured using quantitative PCR (n=143). Area under the curve (AUC) and linear mixed effects models were used to compare ACTH and cortisol response measured across time between groups. RESULTS: There were divergent effects of IBS on the cortisol response to ACTH by sex. In men, IBS was associated with an increased AUC (p=0.009), but in women AUC was blunted in IBS (p=0.006). Men also had reduced GR mRNA expression (p=0.007). Cumulative exposure to EALs was associated with an increased HPA response. Lower GR mRNA was associated with increased pituitary HPA response and increased severity of overall symptoms and abdominal pain in IBS. CONCLUSION: This study highlights the importance of considering sex in studies of IBS and the stress response in general. Our findings also provide support for PBMC GR mRNA expression as a peripheral marker of central HPA response.
BACKGROUND AND AIMS: Dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis has been reported in irritable bowel syndrome (IBS). Enhanced HPA axis response has been associated with reduced glucocorticoid receptor (GR) mediated negative feedback inhibition. We aimed to study the effects of IBS status, sex, or presence of early adverse life events (EAL) on the cortisol response to corticotropin-releasing factor (CRF) and adrenocorticotropic hormone (ACTH), and on GR mRNA expression in peripheral blood mononuclear cells (PBMCs). METHODS: Rome III+ IBSpatients and healthy controls underwent CRF (1μg/kg ovine) and ACTH (250μg) stimulation tests with serial plasma ACTH and cortisol levels measured (n=116). GR mRNA levels were measured using quantitative PCR (n=143). Area under the curve (AUC) and linear mixed effects models were used to compare ACTH and cortisol response measured across time between groups. RESULTS: There were divergent effects of IBS on the cortisol response to ACTH by sex. In men, IBS was associated with an increased AUC (p=0.009), but in women AUC was blunted in IBS (p=0.006). Men also had reduced GR mRNA expression (p=0.007). Cumulative exposure to EALs was associated with an increased HPA response. Lower GR mRNA was associated with increased pituitary HPA response and increased severity of overall symptoms and abdominal pain in IBS. CONCLUSION: This study highlights the importance of considering sex in studies of IBS and the stress response in general. Our findings also provide support for PBMC GR mRNA expression as a peripheral marker of central HPA response.
Authors: S E Pritchard; K C Garsed; C L Hoad; M Lingaya; R Banwait; W Thongborisute; E Roberts; C Costigan; L Marciani; P A Gowland; R C Spiller Journal: Neurogastroenterol Motil Date: 2015-02-20 Impact factor: 3.598
Authors: Colleen H Parker; Bruce D Naliboff; Wendy Shih; Angela P Presson; Elizabeth J Videlock; Emeran A Mayer; Lin Chang Journal: Clin Gastroenterol Hepatol Date: 2019-01-04 Impact factor: 11.382
Authors: S H Park; B D Naliboff; W Shih; A P Presson; E J Videlock; T Ju; L Kilpatrick; A Gupta; E A Mayer; L Chang Journal: Neurogastroenterol Motil Date: 2017-07-18 Impact factor: 3.598
Authors: Isabelle A M van Thiel; Wouter J de Jonge; Isaac M Chiu; Rene M van den Wijngaard Journal: Am J Physiol Gastrointest Liver Physiol Date: 2020-04-20 Impact factor: 4.052